SEC Form 4 · accession 0001104659-15-049023

CATABASIS PHARMACEUTICALS INC · CATB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Jean George

Director

Period of report

Jun 30, 2015

Accepted (ET)

Jun 30, 2015 · 6:47 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001454789

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	Jun 30, 2015	C	674,446	—	A	674,446	I	See Footnote
Common Stock^F1,F2	Jun 30, 2015	C	304,309	—	A	978,755	I	See Footnote
Common Stock^F1,F3	Jun 30, 2015	C	574,979	—	A	574,979	I	See Footnote
Common Stock^F1,F4	Jun 30, 2015	C	78,342	—	A	78,342	I	See Footnote
Common Stock^F2	Jun 30, 2015	P	155,188	$12.00	A	1,133,943	I	See Footnote
Common Stock^F3	Jun 30, 2015	P	91,166	$12.00	A	666,145	I	See Footnote
Common Stock^F4	Jun 30, 2015	P	12,422	$12.00	A	90,764	I	See Footnote

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Series A Preferred Stock^F2,F1	—	Jun 30, 2015	C	8,666,667	D	—	—	Common Stock	674,446	0	I
Series B Preferred Stock^F2,F1	—	Jun 30, 2015	C	3,910,392	D	—	—	Common Stock	304,309	0	I
Series B Preferred Stock^F3,F1	—	Jun 30, 2015	C	7,388,491	D	—	—	Common Stock	574,979	0	I
Series B Preferred Stock^F4,F1	—	Jun 30, 2015	C	1,006,712	D	—	—	Common Stock	78,342	0	I
Stock Option (right to buy)^F5	$12.21	Jun 30, 2015	A	11,094	A	—	Jun 29, 2025	Common Stock	11,094	11,094	D

Explanation of responses

F1The Series A and Series B Preferred Stock converted into Common Stock on a 1-for-12.85 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A and B Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
F2These shares are held directly by Advanced Technology Ventures VIII, L.P. ("ATV VIII"). ATV Associates VIII, LLC ("ATV A VIII") is the General Partner of ATV VIII and exercises voting and dispositive authority over the shares held by ATV VIII. Voting and dispositive decisions of ATV A VIII are made collectively by Michael A. Carusi, Ms. George, Steven N. Baloff, Robert C. Hower and William C. Wiberg (collectively, the "ATV VIII Managing Directors"). Ms. George disclaims beneficial ownership of the shares held by ATV VIII except to the extent of their pecuniary interest therein.
F3These shares are owned directly by Lightstone Ventures, L.P. ("LSV"). LSV Associates, LLC ("LSV GP") is the General Partner of Lightstone Ventures, L.P. and exercises voting and dispositive authority over the shares held by LSV. Voting and dispositive decisions of LSV GP are made collectively by Michael A. Carusi, Jean George, Ralph E. Christoffersen and Henry A. Plain, Jr. Ms. George disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.
F4These shares are owned directly by Lightstone Ventures (A), L.P. ("LSV(A)"). LSV GP is the General Partner of LSV(A) and exercises voting and dispositive authority over the shares held by LSV(A). Voting and dispositive decisions of LSV GP are made collectively by Michael A. Carusi, Jean George, Ralph E. Christoffersen and Henry A. Plain, Jr. Ms. George disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.
F5This option was granted on June 30, 2015 and vests over three years, with one-third of the shares vesting on each anniversary of the grant date until the third anniversary of the grant date.